2025-07-14 - Analysis Report
Okay, here's a report analyzing Transmedics Group Inc. (TMDX) based on the data you provided.

## Transmedics Group Inc. (TMDX) Analysis

Transmedics Group Inc. is a medical technology company that is pioneering a next-generation platform for preserving organs for transplant.

### 1. Performance Overview:

*   **Ticker:** TMDX
*   **Cumulative Return (TMDX):** 229.86%
*   **Cumulative Return (S&P 500 - VOO):** 67.03%
*   **Absolute Divergence (TMDX vs. VOO):** 162.8
*   **Relative Divergence:** 63.0

**Analysis:** TMDX has significantly outperformed the S&P 500 (VOO) over the period examined. The relative divergence of 63.0 suggests that TMDX's outperformance, while substantial, is not at the extreme upper range of its historical divergence, but still indicates a significant degree of outperformance.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD   | Alpha   | Beta | Cap(B) |
| ---------- | ------- | ----- | ------- | ---- | ------ |
| 2019-2021  | -4.0%   | 63.4% | -52.0%  | 0.0  | 0.7    |
| 2020-2022  | 140.0%  | 68.3% | 138.0%  | 0.1  | 2.1    |
| 2021-2023  | 95.0%   | 69.4% | 77.0%   | 0.2  | 2.7    |
| 2022-2024  | 147.0%  | 82.8% | 121.0%  | 0.2  | 2.1    |
| 2023-2025  | 111.0%  | 82.8% | 64.0%   | 0.5  | 3.9    |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate (CAGR) demonstrates impressive growth, especially in recent periods.
*   **MDD:** Maximum Drawdown (MDD) is substantial, indicating significant volatility and risk.
*   **Alpha:** Consistently high alpha values indicate that TMDX is generating returns above what would be expected based on its beta.
*   **Beta:** Beta values suggest that TMDX is more volatile than the market (S&P 500). The increasing beta values in recent years indicate heightened sensitivity to market movements.

### 2. Recent Stock Price Movement:

*   **Current Price:** 112.46
*   **Last-market:** {'price': 114.5, 'previousClose': 112.46, 'change': 1.81}
*   **5-day Moving Average:** 122.71
*   **20-day Moving Average:** 129.75
*   **60-day Moving Average:** 117.84

**Analysis:** The stock price is currently below its 5-day, 20-day and 60-day moving averages, indicating a short-term downtrend. The **Last-market** showed a significant jump of 1.81, suggesting a recent positive market reaction that is not fully reflected in the averages, possibly driven by recent news or events.

### 3. Technical Indicators:

*   **Market Risk Indicator (MRI):** 0.3294 (Low Risk)
*   **RSI:** 38.75 (Approaching Oversold)
*   **PPO:** -1.83 (Bearish Signal)
*   **Hybrid Signal:** cash_69%_Sell 0.7% of holdings (4 shares - Caution - MRI:0.35) (Cash Ratio: 69% on 2025-06-16)
*   **Change in Relative Divergence (20-day):** -3.3 (Short-term decline)
*   **Expected Return:** 57.3% (Long-Term, vs. S&P 500)

**Analysis:**

*   **MRI:** The MRI indicates a low-risk environment, suggesting that the stock is relatively stable compared to the broader market.
*   **RSI:** The Relative Strength Index (RSI) is below 40, indicating that the stock might be approaching oversold conditions, which could lead to a potential bounce.
*   **PPO:** The Percentage Price Oscillator (PPO) is negative, suggesting a bearish trend.
*   **Hybrid Signal:** The hybrid signal recommends selling a small portion of holdings and maintaining a high cash ratio, indicating caution.
*   **Change in Relative Divergence:** The recent decrease in relative divergence suggests a short-term decline in performance compared to the S&P 500.
*   **Expected Return:** The high expected return suggests that analysts are optimistic about the long-term prospects of the stock.

### 4. Recent News & Events:

*   **2025-07-14:** Major business developments, regulatory changes, or market events impacting TMDX.
*   **2025-07-11:** Analyst discussions on TMDX's performance and outlook.
*   **2025-07-13:** Notable volatility in TMDX stock.
*   **2025-07-10:** Market experts highlight both risks and opportunities for TMDX.

**Analysis:** The recent news indicates a period of significant activity and market attention on TMDX, including volatility and analyst discussions. Investors should monitor these developments for potential impacts on the stock.

### 5. Recent Earnings Analysis:

| 날짜        | EPS  | 예상 EPS |
| ----------- | ---- | -------- |
| 2025-05-08  | 0.7  | 0.29     |
| 2025-02-27  | 0.19 | 0.22     |
| 2024-10-28  | 0.12 | 0.29     |
| 2024-07-31  | 0.35 | 0.21     |
| 2024-04-30  | 0.35 | 0.03256  |

**Analysis:**  The company has shown positive EPS surprises in recent quarters, particularly in 2025-05-08, which is a strong indicator of financial health.

### 6. Financial Information:

**Revenue and Profitability:**

| Quarter    | Revenue | Profit Margin |
| ---------- | ------- | ------------- |
| 2025-03-31 | $0.14B | 61.47%        |
| 2024-12-31 | $0.12B | 59.21%        |
| 2024-09-30 | $0.11B | 55.94%        |
| 2024-06-30 | $0.11B | 60.59%        |
| 2024-03-31 | $0.10B | 61.91%        |

**Capital and Profitability:**

| Quarter    | Equity   | ROE      |
| ---------- | -------- | -------- |
| 2025-03-31 | $0.27B  | 9.64%   |
| 2024-12-31 | $0.23B  | 3.00%   |
| 2024-09-30 | $0.21B  | 2.01%   |
| 2024-06-30 | $0.19B  | 6.42%   |
| 2024-03-31 | $0.16B  | 7.65%   |

**Analysis:**

*   **Revenue:** Revenue has been consistently increasing, indicating strong growth.
*   **Profit Margin:** The profit margin is very high and stable, demonstrating efficient operations.
*   **Equity:** Equity is growing, signifying financial stability and reinvestment potential.
*   **ROE:** Return on Equity (ROE) shows variability but an overall increasing trend, which is positive for investors.

### 7. Overall Assessment:

Transmedics Group Inc. (TMDX) shows strong growth potential and has significantly outperformed the S&P 500. High alpha values and a long-term expected return suggest that the company is generating returns above market expectations.  The company's fundamentals appear strong with rising revenue, high-profit margins, and improving ROE.  However, the high maximum drawdown and recent volatility indicate that the stock is risky. The Hybrid Signal recommends caution, selling a small portion of holdings, and maintaining a high cash ratio.

**Recommendation:** Given the mixed signals, investors should exercise caution. Recent analyst discussions, volatility, and EPS beats highlight the dynamic nature of the stock. Long-term, TMDX shows great potential. It is advisable to closely monitor recent news, market events, and analyst opinions before making any investment decisions.
